Summary
n-Butyrate and 12-0-tetradecanoylphorbol-13-acetate (TPA) have been shown to be potent inducers of Epstein-Barrvirus (EBV) antigen synthesis (10, 18) and cell differentiation (1, 2). Activated serum factor (SF) has also been reported to induce virus antigen synthesis and moreover it is capable of cooperative action with other inducers (5). We have demonstrated with an EBV-carrying lymphoma cell line (Raji) that activated SF can also induce the appearance of some cellular alterations, specific for early steps of the productive virus cycle in a low proportion of cells. In addition cell differentiation towards plasma cell was noted in about 8 per cent of SF-treated cells. It was confirmed that activated SF enhances the induction of virus antigens by n-butyrate or TPA as detected by the immunofluorescence technique. It was shown that it also potentiates the development of virus-induced changes in cellular morphology and the cell differentiation induced by these drugs. This effect was more pronounced in combination with TPA than with butyrate. Possible relationships between cell differentiation and virus-antigen expression are discussed.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Anisimová, E., Prachová, K., Roubal, J., Vonka, V.: Effects of n-butyrate and phorbol-ester (TPA) on induction of Epstein-Barr virus antigens and cell differentiation. Arch. Virol.81, 223–237 (1984).
Anisimová, E., Saemundsen, A. K., Roubal, J., Vonka, V., Klein, G.: Effect of n-butyrate on Epstein-Barr virus-carrying lymphoma lines. J. gen. Virol.58, 163–171 (1982).
Anisimová, E., Tučková, E., Vonka, V., Závadová, H.: Ultrastructural changes induced by influenza virus in permissive and nonpermissive cells. Virology77, 330–336 (1977).
Bauer, G.: Quantitative analysis of the cooperative effect between inducers of Epstein-Barr virus antigen synthesis. J. gen. Virol.64, 1337–1346 (1983).
Bauer, G., Höfler, P., zur Hausen, H.: Epstein-Barr virus induction by a serum factor I: Induction and cooperation with additional inducers. Virology121, 184–194 (1982).
Ben Sasson, S. A., Klein, G.: Activation of Epstein-Barr virus genome by 5-azacytidine in latently infected human lymphoid lines. Int. J. Cancer28, 131–135 (1981).
Gerber, P.: Activation of Epstein-Barr virus by 5-bromodeoxyuridine in “virus-free” human cells. Proc. Natl. Acad. Sci. U.S.A.69, 83–85 (1972).
Henle, G., Henle, W.: Immunofluorescence in cells derived from Burkitt's lymphoma. J. Bacteriol.91, 1248–1256 (1966).
Hinuma, Y., Grace, J. T.: Clonning of immunoglobulin producing human leukemia and lymphoma cell lines in long term cultures. Proc. Soc. Exp. Biol. Med.124, 107–111 (1967).
Luka, J., Kallin, B., Klein, G.: Induction of the Epstein-Barr virus (EBV) cycle in latently infected cells by n-butyrate. Virology94, 228–231 (1979).
Magrath, F. T., Pizzo, P. A., Novikovs, L., Levine, A. S.: Enhancement of Epstein-Barr virus replication in producer cell lines by a combination of low temperature and corticosteroids. Virology97, 477–481 (1979).
Miller, G., Lipman, M.: Relase of infectious EBV by marmoset transformed leucocytes. Proc. Natl. Acad. Sci. U.S.A.70, 190–194 (1973).
Pulvertaft, R. J. V.: A study of malignant tumors in Nigeria in short term tissue cultures. J. Clin. Pathol.18, 261–273 (1965).
Reedman, B., Klein, G.: Cellular localization of an Epstein-Barr virus (EBV)-associated complement fixing antigen in producer and non-producer lymphoblastoid cell lines. Int. J. Cancer11, 499–520 (1973).
Tovey, M. G., Lenoir, G., Begon, Lours J.: Activation of latent Epstein-Barr virus by antibody to human IgM. Nature (London)276, 270–272 (1978).
Vonka, V., Vlčková, I., Závadová, H., Kouba, K., Lazovská, J., Duben, J.: Antibodies to Epstein-Barr virus capsid antigen and to soluble antigen of lymphoblastoid cell lines in infectious mononucleosis patients. Int. J. Cancer9, 529–535 (1972).
Wittmann, P., Höfler, P., Bauer, G.: Epstein-Barr virus induction by a serum factor: Ubiquitous occurrence of the factor within vertebrates and its interaction with defined lymphoid cell lines. Int. J. Cancer30, 503–510 (1982).
zur Hausen, H., Bornkamm, G. W., Schmidt, R., Hecker, E.: Tumor initiators and promotors in the induction of Epstein-Barr virus. Proc. Natl. Acad. Sci. U.S.A.76, 782–785 (1979).
Author information
Authors and Affiliations
Additional information
With 6 Figures
Rights and permissions
About this article
Cite this article
Roubalová, K., Anisimová, E. & Roubal, J. Effects of activated serum factor on the induction of Epstein-Barr virus antigens and cell differentiation. Archives of Virology 85, 85–94 (1985). https://doi.org/10.1007/BF01317008
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01317008